Interstitial Lung Disease
-
Third Clinical Year in Review Session Spotlights Key Advances in ILD, Lung Transplant, and More
on
Read more: Third Clinical Year in Review Session Spotlights Key Advances in ILD, Lung Transplant, and MoreThe third ATS 2026 International Conference Clinical Year in Review session on Tuesday, May 19, featured experts discussing updates to guidelines and impactful studies in cystic fibrosis and non-CF bronchiectasis, interstitial lung disease, lung transplant, and environmental lung diseases.
-
Final Clinical Year in Review Sessions Distill Impactful Data Into Pragmatic Strategies
on
Read more: Final Clinical Year in Review Sessions Distill Impactful Data Into Pragmatic StrategiesThis year’s Clinical Year in Review presentations will cover precision approaches that incorporate biologics, endotypes risk scores, and optimal treat-to-target strategies. Ayodeji Adegunsoye, MD, PhD, MSc, series co-chair, said the aim is to empower clinicians with critical, timely information that positively affects patients’ disease trajectory. The final sessions will be held from 9:15–10:45 a.m. on…
-
Pediatric Year in Review Will Highlight Key Advances and Emerging Research
on
Read more: Pediatric Year in Review Will Highlight Key Advances and Emerging ResearchThe “Pediatric Year in Review – The Magic Kingdom of Pediatric Pulmonary” at ATS 2026 Orlando, 2:15–3:45 p.m. on Sunday, will examine impactful and timely discoveries affecting pediatric patients. Christian Rosas-Salazar, MD, MPH, ATSF, chair of the session, expressed his excitement about the lineup of international experts slated to present.